enteroviru
ev
one
genus
famili
picornavirida
includ
coxsackieviru
b
cva
cvb
echoviru
echo
enteroviru
polioviru
pv
caus
wide
spectrum
human
diseas
diseas
hfmd
herpangina
pneumonia
diabet
mellitu
asept
mening
cvb
infect
possibl
caus
fatal
sever
diseas
meningoenceph
unclear
patient
develop
sever
diseas
viru
caus
hfmd
andor
mild
mening
ev
rna
viru
viral
capsid
compris
four
protein
epitop
recogn
neutral
particular
bear
greatest
number
neutral
serolog
ev
categor
serotyp
basi
neutral
test
use
prototyp
virus
neutral
antibodi
also
use
identifi
ev
neonat
mice
tissu
cultur
ninth
report
intern
committe
taxonomi
virus
reclassifi
genu
enteroviru
speci
rhinoviru
b
c
accord
biolog
genet
detect
pathogen
necessari
accur
patholog
diagnos
identifi
relationship
pathogen
immunohistochemistri
ihc
situ
hybrid
ish
use
detect
viral
antigen
genom
tissu
section
nowaday
polymeras
chain
reaction
quantit
real
time
pcr
also
use
detect
viral
genom
use
nucleic
acid
extract
fresh
tissu
andor
tissu
howev
rna
dna
genom
easili
modifi
formalin
week
formalin
fixat
sensit
detect
viral
rna
tissu
fall
approxim
time
compar
fresh
thu
detect
viral
antigen
ihc
use
screen
diagnost
procedur
tissu
section
neonat
mice
cultur
cell
use
posit
control
detect
viral
antigen
genom
ihc
research
use
cultur
cell
posit
control
ihc
wherea
other
use
tissu
neonat
mice
posit
previous
develop
three
polyclon
antibodi
rais
denatur
viru
particl
deriv
pv
diagnosi
patholog
research
diseas
pathogenesi
experiment
gener
anoth
three
polyclon
antibodi
specif
protein
pv
protein
protein
six
polyclon
antibodi
examin
term
specif
differ
enteroviru
serotyp
speci
genera
found
polyclon
antibodi
abl
recogn
sever
ev
serotyp
includ
cva
cvb
echo
pv
ev
examin
studi
list
tabl
clinic
diagnos
symptom
genotyp
access
number
cell
use
assay
infect
neonat
mice
predomin
serotyp
ev
isol
case
asept
mening
japan
period
select
rhesu
monkey
kidney
epitheli
cell
rhabdomyosarcoma
rd
cell
grown
minim
essenti
medium
mem
supplement
fetal
bovin
serum
fb
cell
prototyp
virus
obtain
american
type
cultur
collect
atcc
manassa
va
usa
polyclon
antibodi
test
pv
isol
examin
util
detect
clinic
isol
cell
cultur
isol
classifi
use
neutral
assay
antisera
examin
capsid
region
sequenc
strain
isol
strain
isol
japan
strain
isol
patient
acut
flaccid
paralysi
associ
polioviru
philippin
nigeria
human
parechoviru
hpev
saffold
viru
safv
encephalomyocard
viru
emcv
use
assess
polyclon
antibodi
exist
picornavirus
strain
safv
isol
public
health
institut
kochi
prefectur
japan
kindli
suppli
dr
cell
disrupt
two
three
cycl
prepar
viru
solut
cell
cultur
infect
dose
calcul
method
basi
cytopath
effect
cpe
observ
cell
monolay
incub
vari
dilut
determin
anim
inocul
six
polyclon
antibodi
prepar
use
studi
three
rais
denatur
viru
particl
isol
genogroup
b
accord
phylogenet
analysi
region
isol
genogroup
c
mahoney
strain
three
antibodi
produc
immun
new
zealand
white
rabbit
viral
particl
denatur
sodium
dodecyl
sulfat
sd
moll
phosphat
buffer
salin
pb
min
previous
two
polyclon
antibodi
protein
prepar
follow
region
cdna
amplifi
pcr
fragment
clone
bamhi
ecori
site
vector
ge
healthcar
life
scienc
littl
chalfont
uk
follow
procedur
recommend
manufactur
vector
use
transform
escherichia
coli
strain
takara
bio
shiga
japan
express
fusion
protein
induc
cell
pellet
sonic
inclus
bodi
contain
fusion
protein
collect
fusion
protein
purifi
use
immun
new
zealand
white
rabbit
previous
antibodi
gener
follow
antibodi
rais
peptid
within
compris
amino
acid
well
conserv
among
ev
expect
detect
mani
ev
follow
ev
protein
sequenc
extract
genbank
databas
amino
acid
sequenc
peptid
follow
cqmvstvefippmasleekg
sequenc
show
high
homolog
compar
ev
peptid
homolog
sequenc
submit
antibodi
product
servic
st
loui
mo
usa
commerci
mous
monoclon
antibodi
clone
dako
denmark
glostrup
denmark
use
posit
control
immunofluoresc
assay
ifa
western
blot
wb
ihc
stain
antibodi
react
ev
epitop
capsid
protein
normal
rabbit
serum
dako
denmark
use
neg
control
ifa
wb
ihc
cytopath
effect
observ
rd
cell
h
infect
cell
lyse
assay
buffer
cell
debri
remov
centrifug
lysat
cell
infect
infect
hpev
safv
emcv
use
neg
control
picornaviru
protein
separ
nupag
precast
gel
novex
life
technolog
corpor
carlsbad
ca
usa
electrophoret
transfer
onto
polyvinyliden
difluorid
pvdf
membran
merck
millipor
billerica
usa
pvdf
membran
block
pvdf
block
reagent
get
signal
toyobo
co
ltd
osaka
japan
overnight
membran
incub
h
appropri
primari
antibodi
dilut
get
signal
immunoreact
enhanc
solut
toyobo
wash
three
time
min
tween
tri
buffer
solut
membran
incub
appropri
horseradish
secondari
antibodi
abcam
cambridg
uk
h
signal
develop
use
immobilon
western
chemiluminesc
reagent
merck
millipor
detect
use
imagequ
digit
imag
system
ge
healthcar
uk
ltd
uk
rd
cell
seed
nunc
well
chamber
slide
thermo
fisher
scientif
inc
waltham
usa
cultur
mem
supplement
fb
day
cell
inocul
picornaviru
multipl
infect
incub
h
day
day
cpe
recogn
less
cell
infect
cell
monolay
fix
sucros
pb
room
temperatur
rt
min
follow
methanolaceton
min
three
wash
triton
pb
cell
incub
min
pb
contain
fb
follow
overnight
incub
antibodi
three
wash
triton
pb
cell
incub
alexa
fluor
goat
igg
h
l
alexa
fluor
goat
igg
h
l
molecular
probe
life
technolog
corp
carlsbad
ca
usa
antibodi
min
rt
cell
counterstain
slowfad
gold
antifad
reagent
dapi
invitrogen
life
technolog
corp
viral
antigen
green
cell
nuclei
blue
visual
use
laser
scan
confoc
microscop
olympu
tokyo
japan
pregnant
ddi
mice
purchas
japan
slc
shizuoka
japan
newborn
mice
inocul
intracerebr
ic
viru
solut
mice
clinic
observ
sacrif
earli
infect
onset
seriou
neurolog
manifest
day
n
day
formalin
perfus
directli
heart
mice
sacrific
excess
dose
anesthesia
isofluran
tissu
immers
formalin
solut
overnight
whole
head
includ
brain
cut
sagitt
section
immers
formalin
solut
day
fixat
section
dehydr
ethanol
solut
decalcifi
buffer
edta
solut
dojindo
kumamoto
japan
sampl
embed
paraffin
stain
anim
experi
includ
rabbit
immun
approv
committe
experiment
anim
nation
institut
infecti
diseas
japan
experiment
anim
handl
accord
guidelin
set
committe
rd
cell
infect
isol
strain
four
isol
pv
four
isol
vaccin
strain
two
isol
prototyp
strain
echo
day
cell
fix
formalin
overnight
embed
ipgel
geno
staff
tokyo
japan
follow
paraffin
accord
manufactur
instruct
detect
system
use
immunohistochem
analysi
antigen
retriev
deparaffin
section
place
retriev
solut
ph
nichirei
bioscienc
inc
tokyo
japan
heat
min
autoclav
wash
pb
section
treat
min
hydrogen
peroxid
methanol
quench
endogen
peroxidas
activ
wash
section
incub
normal
goat
serum
dako
denmark
rt
min
follow
overnight
incub
primari
polyclon
antibodi
wash
pb
section
incub
simpl
stain
mous
max
po
r
nichirei
bioscienc
accord
manufactur
protocol
peroxidas
activ
detect
section
counterstain
hematoxylin
specif
background
seen
aceton
powder
prepar
normal
neonat
adult
mous
spleen
liver
brain
tissu
use
block
spuriou
activ
powder
mg
ad
ml
polyclon
sera
incub
overnight
centrifug
g
min
supernat
use
ihc
ev
gene
sequenc
isol
amplifi
use
hybrid
oligonucleotid
primer
codehop
pcr
method
primer
describ
nix
et
viral
rna
extract
cell
cultur
use
rneasi
plu
mini
kit
qiagen
hilden
germani
cdna
gener
use
four
differ
primer
primer
superscript
ii
transcriptas
invitrogen
life
technolog
corpor
cdna
use
pcr
primer
pcr
product
amplifi
nest
pcr
use
primer
amplifi
dna
sequenc
use
abi
genet
analyz
appli
biosystem
life
technolog
corp
nucleotid
sequenc
obtain
nation
institut
public
health
environ
bilthoven
netherland
databas
use
ev
genotyp
tool
version
identifi
ev
serotyp
highest
sequenc
nucleotid
sequenc
three
ev
isol
align
use
sequench
ver
gene
code
corpor
ann
arbor
mi
usa
nucleotid
sequenc
analyz
studi
submit
dna
data
bank
japan
ddbj
tabl
reactiv
antisera
rais
rabbit
evalu
wb
picornaviru
protein
deriv
ev
cell
lysat
fig
polyclon
antibodi
specif
correspond
ev
antigen
although
show
ev
antigen
howev
none
polyclon
antibodi
recogn
antigen
includ
hpev
safv
emcv
wb
reveal
picornaviru
particl
antibodi
recogn
mainli
approxim
kda
correspond
viral
strain
although
show
background
stain
fig
c
upper
panel
antibodi
antibodi
show
broad
cva
cvb
pv
antibodi
kda
serotyp
includ
cvb
echo
fig
antibodi
specif
protein
serotyp
fig
middl
panel
antibodi
recogn
antigen
kda
protein
hev
serotyp
fig
lower
panel
commerci
monoclon
antibodi
clone
detect
protein
cvb
echo
fig
ifa
perform
examin
specif
six
polyclon
antibodi
ev
first
confirm
cultur
cell
infect
ev
serotyp
show
cpe
includ
cytolysi
degener
six
polyclon
antibodi
detect
viru
antigen
origin
cell
fix
paraformaldehyd
lyse
triton
degener
cell
posit
viral
antigen
ifa
fig
antibodi
recogn
capsid
antigen
cell
cytoplasm
antigen
posit
perinuclear
region
antibodi
cva
cvb
pv
tabl
antibodi
react
cvb
antigen
also
echo
strain
pv
antibodi
recogn
pv
serotyp
serotyp
howev
antibodi
recogn
three
pv
serotyp
show
broad
cva
cvb
echo
none
polyclon
antibodi
recogn
antigen
none
react
cell
next
neonat
mice
infect
picornaviru
examin
specif
polyclon
antibodi
viral
antigen
mous
tissu
ihc
previous
describ
mous
tissu
sampl
also
block
cell
use
instead
tissu
sampl
echo
infect
neonat
mice
microscop
lesion
foci
degener
cell
necrot
cell
andor
inflamm
skelet
muscl
nerv
tissu
confirm
histopatholog
stain
fig
f
almost
degener
cell
posit
viral
capsid
antigen
fig
c
e
polyclon
antibodi
recogn
correspond
ev
antigen
ev
fig
tabl
none
polyclon
antibodi
recogn
antigen
deriv
hpev
safv
commerci
monoclon
antibodi
show
strong
reactiv
mous
tissu
addit
ihc
reveal
antibodi
tabl
antibodi
show
broad
antigen
wherea
antibodi
includ
cvb
echo
pv
serotyp
recogn
pv
serotyp
includ
cva
viru
capsid
antigen
viral
antigen
detect
cytoplasm
degener
neuron
icr
mice
infect
virul
lans
strain
fig
addit
perform
histopatholog
analysi
nerv
brain
spinal
cord
skelet
muscl
feet
heart
mucos
epithelium
oral
caviti
neonat
ddi
mice
intracerebr
inocul
ev
prototyp
strain
clinic
isol
tabl
ihc
use
polyclon
antibodi
identifi
viral
antigen
patholog
lesion
neonat
mice
cva
virus
belong
speci
appear
mainli
infect
skelet
muscl
case
nerv
cell
epitheli
cell
howev
cvb
virus
belong
speci
infect
broad
rang
tissu
includ
neuron
skelet
muscl
mucos
epithelium
exocrin
gland
liver
brown
fat
data
shown
examin
util
polyclon
antibodi
examin
cell
infect
clinic
isol
pv
obtain
fig
six
polyclon
antibodi
show
ident
recognit
pattern
serotyp
tabl
amino
acid
sequenc
differ
viru
isol
harbor
mutat
exampl
compar
amino
acid
sequenc
nanci
strain
sequenc
clinic
isol
harbor
eight
amino
acid
chang
region
span
amino
acid
hand
isol
harbor
two
amino
acid
differ
compar
sequenc
amino
acid
sequenc
pv
isol
strain
show
differ
degre
homolog
mahoney
strain
site
amino
acid
differ
site
site
site
seven
site
antibodi
gener
previou
studi
rais
denatur
viru
particl
recogn
major
protein
made
immunogen
heat
exposur
ev
harbor
sever
linear
epitop
within
structur
protein
immunosorb
assay
use
sera
patient
reveal
reactiv
peptid
deriv
conserv
region
mediat
viral
attach
target
cell
bear
sever
neutral
epitop
howev
also
share
epitop
ev
antibodi
appear
recogn
linear
epitop
antigen
antibodi
result
greater
ev
although
background
stain
also
higher
addit
examin
reactiv
antibodi
denatur
viru
particl
note
differ
reactiv
depend
techniqu
ifa
wb
ihc
use
also
examin
fusion
protein
antibodi
recogn
capsid
protein
antibodi
show
similar
reactiv
depend
assay
ifa
wb
ihc
also
rais
polyclon
antibodi
pv
highli
conserv
among
ev
genet
analysi
amino
acid
region
suggest
protein
mani
function
includ
serin
proteas
inhibitor
regul
pv
proteas
activ
viral
aim
present
studi
develop
antibodi
could
detect
serotyp
ev
inde
antibodi
recogn
wb
experi
howev
recogn
pv
ihc
analys
addit
antibodi
gener
high
background
signal
use
examin
monkey
human
tissu
data
shown
commerci
monoclon
antibodi
clone
broadli
ev
recogn
ev
epitop
locat
hansson
et
al
recent
report
clone
also
recogn
two
human
mitochondri
enzym
atp
synthas
subunit
beta
creatin
kinas
ckbb
mitochondri
enzym
prevent
block
specimen
solut
contain
excess
anoth
commerci
monoclon
antibodi
also
avail
although
rhinoviru
coronaviru
herp
viru
anim
tissu
sampl
obtain
experiment
infect
similar
human
specimen
cultur
cell
thu
use
evalu
bind
use
tissu
sampl
neonat
mice
infect
prototyp
viru
ev
isol
possibl
echo
viru
infect
mice
common
problem
associ
polyclon
antibodi
ihc
tissu
sampl
human
anim
high
level
background
stain
due
bind
specif
solv
use
tissu
cultur
cell
prepar
block
bind
also
purifi
igg
fraction
attempt
reduc
treatment
mostli
work
well
although
higher
antibodi
concentr
need
assay
data
shown
treatment
aceton
powder
success
reduc
bind
pv
antibodi
examin
specimen
anim
pv
enceph
experiment
also
examin
six
polyclon
antibodi
picornavirus
includ
hpev
safv
import
distinguish
ev
infect
hpev
safv
infect
hpev
safv
isol
infant
gastroenter
respiratori
ill
patient
acut
flaccid
paralysi
asept
mening
enceph
myocard
neonat
neither
hpev
safv
six
polyclon
antibodi
current
result
show
none
six
polyclon
antibodi
specif
particular
serotyp
speci
howev
antibodi
human
picornavirus
short
antibodi
specif
genu
ev
sinc
hfmd
outbreak
malaysia
epidem
occur
cyclic
asian
infect
may
result
neurolog
complic
asept
mening
fatal
enceph
addit
cvb
echo
infect
report
sever
countri
undertak
surveil
acut
flaccid
paralysi
effect
control
virus
import
erad
countri
develop
new
vaccin
neonat
mice
candid
anim
model
evalu
vaccin
neonat
mice
use
viru
isol
neutral
studi
identifi
differ
ev
small
murin
model
picornaviru
infect
conveni
use
immunolog
analys
howev
sensit
rodent
picornaviru
infect
differ
human
thu
necessari
understand
differ
sensit
human
rodent
model
studi
pathogenesi
develop
vaccin
agent
instanc
pathogen
mechan
neonat
mice
studi
seem
differ
human
case
sever
encephalomyel
addit
neonat
mice
viral
antigen
present
muscl
cn
howev
evid
viru
infect
muscl
human
thu
need
care
evalu
neonat
mous
six
polyclon
antibodi
describ
herein
use
evalu
patholog
dissimilar
enteroviru
infect
human
experiment
anim
thu
data
contribut
futur
studi
picornaviru
infect
use
ifa
wb
ihc
analys
show
six
polyclon
antibodi
recogn
antigen
deriv
correspond
immun
virus
although
specif
antibodi
ev
low
abl
distinguish
differ
ev
serotyp
specif
ev
genu
recogn
genera
hpev
safv
addit
note
detect
viral
antigen
tissu
specimen
depend
upon
phase
infect
thu
clinician
virologist
pathologist
must
collabor
ensur
definit
diagnosi
picornaviru
infect
also
tissu
sampl
avail
ihc
pcr
andor
ish
perform
conclus
present
studi
establish
panel
polyclon
antibodi
suitabl
patholog
diagnosi
picornaviru
infect
cva
cvb
echo
pv
result
help
facilit
futur
diagnosi
research
pathogenesi
ev
infect
